Overall, these data showed that, unlike CT26/HER2 cells, 4T1.2/HER2 cells induced HER263–71-specific CD8+ CTLs, leading to tumor regression, and that CD80 molecules were not associated with this tumor regression. The gene discussed is ERBB2; the disease is neoplasm.